Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Toxicol Appl Pharmacol
; 348: 1-13, 2018 06 01.
Article
in En
| MEDLINE
| ID: mdl-29653124
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_energeticas
/
Bioenergetica
Main subject:
Doxorubicin
/
Tumor Suppressor Protein p53
/
Myocytes, Cardiac
/
Energy Metabolism
/
Induced Pluripotent Stem Cells
/
Heart Diseases
/
Antibiotics, Antineoplastic
Language:
En
Journal:
Toxicol Appl Pharmacol
Year:
2018
Type:
Article